The 21st Century Cures Act has sparked debate since its passage in the last days of the Obama presidency. The law promises to ramp up funding for biomedical research while it also loosens regulations governing drugs and medical devices. Supporters say it will speed up approval of new treatments, while critics are concerned that the safety and effectiveness may be compromised.
To debate these points and other implications of the law — whose implementation will be a major priority for the new FDA commissioner soon to be appointed by President Trump — the Forum at the Harvard T.H. Chan School of Public Health invited experts to participate in an hour-long panel discussion. Presented jointly with STAT, the event video is below.